These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27255644)

  • 1. Hyponatremia at discharge as a predictor of 12-month clinical outcomes in hospital survivors after acute myocardial infarction.
    Bae MH; Kim JH; Jang SY; Park SH; Lee JH; Yang DH; Park HS; Cho Y; Chae SC
    Heart Vessels; 2017 Feb; 32(2):126-133. PubMed ID: 27255644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction.
    Burkhardt K; Kirchberger I; Heier M; Zirngibl A; Kling E; von Scheidt W; Kuch B; Meisinger C
    Eur J Prev Cardiol; 2015 Nov; 22(11):1419-26. PubMed ID: 25389071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction.
    Bae MH; Lee JH; Lee SH; Park SH; Yang DH; Park HS; Cho Y; Jun JE; Chae SC
    Circ J; 2011; 75(6):1440-7. PubMed ID: 21498911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Nassar M; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Beyar R; Markiewicz W; Aronson D
    Arch Intern Med; 2006 Apr; 166(7):781-6. PubMed ID: 16606816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).
    Lee JH; Park HS; Chae SC; Cho Y; Yang DH; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH;
    Am J Cardiol; 2009 Jul; 104(2):182-9. PubMed ID: 19576343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
    Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K
    JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction.
    Cho J; Park IB; Lee K; Ahn TH; Park WB; Kim JH; Ahn Y; Jeong MH; Lee DH;
    J Cardiol; 2018 Apr; 71(4):375-381. PubMed ID: 29158023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction.
    Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Cho MC; Kim CJ; Chae SC;
    Am J Cardiol; 2015 May; 115(9):1167-73. PubMed ID: 25772739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of hyponatremia occurring at various time points during hospitalization on mortality in patients with acute myocardial infarction.
    Choi JS; Kim CS; Bae EH; Ma SK; Ahn YK; Jeong MH; Kim SW
    Medicine (Baltimore); 2017 Jun; 96(23):e7023. PubMed ID: 28591032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
    Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Chae SC;
    Korean J Intern Med; 2016 Mar; 31(2):267-76. PubMed ID: 26701233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction.
    Lee JW; Choi E; Khanam SS; Son JW; Youn YJ; Ahn MS; Ahn SG; Kim JY; Lee SH; Yoon J; Yoo BS
    Int J Cardiol; 2019 Aug; 289():19-23. PubMed ID: 30638981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.
    Pouche M; Ruidavets JB; Ferrières J; Iliou MC; Douard H; Lorgis L; Carrié D; Brunel P; Simon T; Bataille V; Danchin N
    Arch Cardiovasc Dis; 2016 Mar; 109(3):178-87. PubMed ID: 26711546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.